Latest news with #BIO-keyInternational
Business Insider
03-05-2025
- Business
- Business Insider
Analysts Offer Insights on Industrial Goods Companies: Thomson Reuters (TRI) and BIO-key International (BKYI)
Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Thomson Reuters (TRI – Research Report) and BIO-key International (BKYI – Research Report). Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Thomson Reuters (TRI) In a report released yesterday, Maher Yaghi from Scotiabank downgraded Thomson Reuters to Hold. The company's shares closed last Friday at $184.51. According to Yaghi is a 4-star analyst with an average return of 4.5% and a 59.8% success rate. Yaghi covers the NA sector, focusing on stocks such as Cogeco Communications, Rogers Communication, and T Mobile US. Currently, the analyst consensus on Thomson Reuters is a Moderate Buy with an average price target of $188.13, which is a 1.9% upside from current levels. In a report issued on April 28, RBC Capital also maintained a Hold rating on the stock with a $182.00 price target. Maxim Group analyst Jack Vander Aarde reiterated a Buy rating on BIO-key International yesterday. The company's shares closed last Friday at $0.83, close to its 52-week low of $0.52. The the analyst consensus on BIO-key International is currently a Hold rating.
Yahoo
29-03-2025
- Business
- Yahoo
BIO-key International Full Year 2024 Earnings: US$2.10 loss per share (vs US$15.21 loss in FY 2023)
Revenue: US$6.93m (down 11% from FY 2023). Net loss: US$4.32m (loss narrowed by 49% from FY 2023). US$2.10 loss per share (improved from US$15.21 loss in FY 2023). The end of cancer? These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. All figures shown in the chart above are for the trailing 12 month (TTM) period BIO-key International shares are down 23% from a week ago. It is worth noting though that we have found 5 warning signs for BIO-key International (4 can't be ignored!) that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Associated Press
20-03-2025
- Business
- Associated Press
Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET
HOLMDEL, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2024 investor call Thursday, March 27th at 10 a.m. ET. Results will be released before the market opens on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. About BIO-key International, Inc. ( BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions. Investor Contacts William Jones, David Collins Catalyst IR [email protected] 212-924-9800
